NCT02156700 Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors Status COMPLETED Phase N/A
NCT02151864 LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 Cirrhosis Status COMPLETED Phase PHASE1
NCT02147301 TACE Using Doxorubicin-eluting Beads for Patients With HCC and Marginal Hepatic Reserve Status TERMINATED Phase NA
NCT02131441 Surgical Specification and Efficacy Evaluation of Total Laparoscopic Left Liver Resection Status UNKNOWN Phase NA
NCT02129322 Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1 Status WITHDRAWN Phase PHASE2
NCT02128958 Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC) Status COMPLETED Phase PHASE2
NCT02113865 Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients Status COMPLETED Phase N/A
NCT02112656 Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC) Status COMPLETED Phase PHASE3
NCT02109146 Postoperative TACE(Transhepatic Arterial Chemotherapy And Embolization) for Patients With Hepatocellular Carcinoma Status COMPLETED Phase PHASE3
NCT02102022 Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma Status TERMINATED Phase PHASE1/PHASE2
NCT02101593 Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer Status COMPLETED Phase PHASE1
NCT02095678 Assessment of Novel MRI Quantification Free Breathing Technique in Evaluation of Liver Lesions Status COMPLETED Phase NA
NCT02089763 Efficacy Study of Pegylated Recombinant Human Arginase 1 as a Second-line Therapy in Patients With Advanced Liver Cancer Status COMPLETED Phase PHASE2
NCT02089633 Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCC Status COMPLETED Phase PHASE2
NCT02082691 Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma Status NO_LONGER_AVAILABLE Phase N/A
NCT02074202 To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma Status UNKNOWN Phase PHASE3
NCT02061956 A Simple Prognostic Scoring System for Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma Status COMPLETED Phase N/A